西尾福 英之 にしおふく ひでゆき 先生

来歴等

略歴

2003年 奈良県立医科大学 卒業
2005年 愛知県がんセンター中央病院　放射線診断・IVR部 レジデント
2009年 奈良県立医科大学　放射線医学教室 助教
2016年 米国MDアンダーソンがんセンター 留学
2017年 奈良県立医科大学　放射線医学教室 講師

論文

• Improved local tumor control and survival rates by obtaining a 3D-safety margin in superselective transarterial chemoembolization for small hepatocellular carcinoma. Cardiovasc Intervent Radiol. 2020 Mar;43(3):423-433.

  Kattipatanapong T, Nishiofuku H, Tanaka T, Sato T, Masada T, Tatsumoto S, Matsumoto T, Kichikawa K.

• Efficacy of combined bland embolization and chemoembolization for huge (≥10 cm) hepatocellular carcinoma. Minim Invasive Ther Allied Technol. 2020 Feb 7:1-8.

  Hidaka T, Anai H, Sakaguchi H, Sueyoshi S, Tanaka T, Yamamoto K, Morimoto K, Nishiofuku H, Maeda S, Nagata T, Kichikawa K.

• Hepatic Arterial Infusion Chemotherapy of 5-Fluorouracil for Patients with Unresectable Liver Metastases from Colorectal Cancer Refractory to Standard Systemic Chemotherapy: A Multicenter Retrospective Study. Oncology. 2020;98(5):267-272.

  Sato Y, Inaba Y, Aramaki T, Sone M, Morita Y, Nishiofuku H, Tanaka T, Miyazaki M, Matsueda K, Arai Y.

• Hepatic Arterial Bland Embolization Increases Th17 Cell Infiltration in a Syngeneic Rat Model of Hepatocellular Carcinoma. Cardiovasc Intervent Radiol. 2020 Feb;43(2):311-321.

  Avritscher R, Jo N, Polak U, Cortes AC, Nishiofuku H, Odisio BC, Takaki H, Tam AL, Melancon MP, Yevich S, Qayyum A, Kaseb A, Kichikawa K, Gupta S, Goldberg SN, Chang SH.

• Use of a Glass Membrane Pumping Emulsification Device Improves Systemic and Tumor Pharmacokinetics in Rabbit VX2 Liver Tumor in Transarterial Chemoembolization. J Vasc Interv Radiol. 2020 Feb;31(2):347-351.

  Masada T, Tanaka T, Nishiofuku H, Fukuoka Y, Taiji R, Sato T, Tatsumoto S, Minamiguchi K, Marugami N, Kichikawa K.

• Hepatic Artery Embolization Induces the Local Overexpression of Transforming Growth Factor β1 in a Rat Hepatoma Model. Liver Cancer. 2020 Jan;9(1):63-72.

  Ueshima E, Nishiofuku H, Takaki H, Hirata Y, Kodama H, Tanaka T, Kichikawa K, Yamakado K, Okada T, Sofue K, Yamaguchi M, Sugimoto K, Murakami T.

• Drug Release Property of Lipiodol Emulsion Formed by Glass Membrane Emulsification Device for Transarterial Chemoembolization. Cardiovasc Intervent Radiol. 2020 Jan;43(1):135-139.

  Tanaka T, Nishiofuku H, Masada T, Fukuoka Y, Sato T, Tatsumoto S, Matsumoto T, Marugami N, Fujihara M, Kichikawa K.

• Selective TACE with irinotecan-loaded 40 μm microspheres and FOLFIRI for colorectal liver metastases: phase I dose escalation pharmacokinetic study. BMC Cancer. 2019 Aug 1;19(1):758.

  Tanaka T, Sato T, Nishiofuku H, Masada T, Tatsumoto S, Marugami N, Otsuji T, Kanno M, Koyama F, Sho M, Kichikawa K.

• Safety and Prognosis of Transarterial Chemoembolization for Octogenarians with Hepatocellular Carcinoma. Cardiovasc Intervent Radiol. 2019 Oct;42(10):1413-1419.

  Cheng HM, Tanaka T, Nishiofuku H, Chanoki Y, Horiuchi K, Masada T, Tatsumoto S, Matsumoto T, Marugami N, Kichikawa K.

• Factors impacting technical success rate of image-guided intra-arterial therapy in rat orthotopic liver tumor model. Am J Transl Res. 2019 Jun 15;11(6):3761-3770.

  Nishiofuku H, Cortes AC, Ensor JE, Minhaj AA, Polak U, Lopez MS, Kiefer R, Hunt SJ, Kichikawa K, Hicks ME, Gade TP, Avritscher R.

• Angiographic Atlas of the Visceral Vascular Anatomy in Translational Rat Models. J Vasc Interv Radiol. 2019 Jun 12. pii: S1051-0443(19)30299-4.

  Shi D, Kiefer RM, Nishiofuku H, Cortes A, Nadolski GJ, Hunt SJ, Avritscher R, Gade TPF.

• Development of Repeatable Microcatheter Access Port for Intra-arterial Therapy of Liver Cancer. Cardiovasc Intervent Radiol. 2019 Feb;42(2):298-303.

  Fukuoka Y, Tanaka T, Nishiofuku H, Sato T, Masada T, Tatsumoto S, Marugami N, Sakaguchi H, Kichikawa K.

• Multicenter Phase II Clinical Trial of Sorafenib Combined with Transarterial Chemoembolization for Advanced Stage Hepatocellular Carcinomas (Barcelona Clinic Liver Cancer Stage C): STAB Study. J Vasc Interv Radiol,29(8)1061-1067,2018

  Sato Y, Nishiofuku H, Yasumoto T, Nakatsuka A, Matsuo K, Kodama Y, Okubo H, Abo D, Takaki H, Inaba Y, Yamakado K.

• Superabsorbent Polymer Microspheres Prepared with Hypertonic Saline to Reduce Microsphere Expansion. Cardiovasc Intervent Radiol,41(9)1412-1418,2018

  Sato T, Tanaka T, Nishiofuku H, Fukuoka Y, Masada T, Tatsumoto S, Marugami N, Morita K, Obayashi C, Hori S, Kaneko M, Kijima A, Kichikawa K.

• Development of pumping emulsification device with glass membrane to form ideal lipiodol emulsion in transarterial chemoembolization. Eur Radiol,28(5)2203-2207,2018

  Tanaka T, Masada T, Nishiofuku H, Fukuoka Y, Sato T, Tatsumoto S, Marugami N, Higashi S, Kichikawa K.

• Outcomes of a Phase I/II Trial of Hepatic Arterial Infusion of Oxaliplatin Combined with Intravenous 5-Fluorouracil and l-Leucovorin in Patients with Unresectable Liver Metastases from Colorectal Cancer After Systemic Chemotherapy Failure.J Gastrointest Cancer,49(2)132-137,2018

  Sato Y, Inaba Y, Ura T, Nishiofuku H, Yamaura H, Kato M, Takahari D, Tanaka T, Muro K.

• Sorafenib versus Hepatic Arterial Infusion Chemotherapy as Initial Treatment for Hepatocellular Carcinoma with Advanced Portal Vein Tumor Thrombosis.Liver Cancer,6(4)275-286,2017

  Moriguchi M, Aramaki T, Nishiofuku H, Sato R, Asakura K, Yamaguchi K, Tanaka T, Endo M, Itoh Y.

• Techniques to Form a Suitable Lipiodol-Epirubicin Emulsion by Using 3-Way Stopcock Methods in Transarterial Chemoembolization for Liver Tumor.J Vasc Interv Radiol,28(10)1461-1466,2017

  Masada T, Tanaka T, Nishiofuku H, Fukuoka Y, Sato T, Tatsumoto S, Marugami N, Kichikawa K.

• Intraarterial Therapy Using Micellar Nanoparticles Incorporating SN-38 in a Rabbit Liver Tumor Model. J Vasc Interv Radiol,28(3)457-464,2017

  Nishiofuku H, Tanaka T, Fukuoka Y, Sato T, Masada T, Tatsumoto S, Sho M, Yamato I, Yasuda S, Matsushima S, Takano M, Ohbayashi C, Kichikawa K.

• Pharmacokinetics and Histopathological Findings of Chemoembolization Using Cisplatin Powder Mixed with Degradable Starch Microspheres in a Rabbit Liver Tumor Model. Cardiovasc Intervent Radiol,40(3)438-444,2017

  Sato T, Tanaka T, Nishiofuku H, Fukuoka Y, Sakaguchi H, Masada T, Tatsumoto S, Marugami N, Takano M, Yamato I, Sho M, Ohbayashi C, Hirai T, Kichikawa K.

• Equivalent cross-relaxation rate imaging and diffusion weighted imaging for early prediction of response to bevacizumab-containing treatment in colorectal liver metastases-preliminary study.Clin Imaging,41,1-6,2017

  Matsushima S, Sato T, Nishiofuku H, Sato Y, Murata S, Kinosada Y, Era S, Inaba Y.

• Adjuvant Hepatic Arterial Infusion Chemotherapy After Resection for Pancreatic Cancer Using Coaxial Catheter-Port System Compared with Conventional System. Cardiovasc Intervent Radiol,39(6) 831-9,2016

  Hashimoto A, Tanaka T, Sho M, Nishiofuku H, Masada T, Sato T, Marugami N, Anai H, Sakaguchi H, Kanno M, Tamamoto T, Hasegawa M, Nakajima Y, Kichikawa K.

• Increased tumor ADC value during chemotherapy predicts improved survival in unresectable pancreatic cancer. European Radiology. 2015 26(6) 1835-42,2016.

  Nishiofuku H, Tanaka T, Marugami N, Sho M, Akahori T, Nakajima Y, Kichikawa K.

• Compatibility of an Ultraselective Microcatheter and Epirubicin Loaded 300-500-μm DC Bead in Ex Vivo Study. Cardiovasc Intervent Radiol. 2015 38(5)1284-7

  Fukuoka Y, Tanaka T, Nishiofuku H, Sato T, Kichikawa K.

• Current role of hybrid CT/angiography system compared with C-arm cone beam CT for interventional oncology. Br J Radiol. 2014 Sep;87(1041):20140126.

  Tanaka T, Arai Y, Inaba Y, Inoue M, Nishiofuku H, Anai H, Hori S, Sakaguchi H, Kichikawa K.

• Pharmacokinetics and antitumor efficacy of chemoembolization using 40 µm irinotecan-loaded microspheres in a rabbit liver tumor model. J Vasc Interv Radiol. 2014 Jul;25(7):1037-1044.

  Tanaka T, Nishiofuku H, Hukuoka Y, Sato T, Masada T, Takano M, Gilbert CW, Obayashi C, Kichikawa K.

• An early-stage, non-hypervascular HCC successfully treated by superselective, bland transarterial embolization using 40-μm microspheres. Anticancer Res. 2014 Apr;34(4):1947-51.

  Tanaka T, Maeda S, Nishiofuku H, Masada T, Sato T, Anai H, Sakaguchi H, Kichikawa K.

• Coils versus gelatin particles with or without intraarterial antibiotics for partial splenic embolization: a comparative evaluation. J Vasc Interv Radiol. 2014 Jun;25(6):852-8.

  Masada T, Tanaka T, Sakaguchi H, Nakagomi M, Miura Y, Hidaka T, Sato Y, Sato T, Inoue M, Furuich K, Nishiofuku H, Kichikawa K.

• Guidelines on the use of gelatin sponge particles in embolotherapy. Jpn J Radiol. 2014 Apr;32(4):242-50.

  Miyayama S, Yamakado K, Anai H, Abo D, Minami T, Takaki H, Kodama T, Yamanaka T, Nishiofuku H, Morimoto K, Soyama T, Hasegawa Y, Nakamura K, Yamanishi T, Sato M, Nakajima Y.

著書

• 図説 胆道IVR経皮インターベンションのすべて,株式会社メジカルビュー社,2015年

特許

• 特許；6398028、穿刺針保持器

その他

• 【受賞】2006　The best paper award, The Japanese society of Interventional radiology

• 【受賞】2009　The best paper, Japanese Society of Implantable Port

• 【受賞】2010　The best paper, Society for Research of Loco-regional Cancer Therapy

• 【受賞】2012　The best paper, Japanese Society of Clinical Oncology

• 【受賞】2013　The best paper, Japanese Society of Implantable Port

• 【受賞】2014　JVIR Editor’s Award: Outstanding Clinical Research Paper

• 【受賞】2014　Cum Laude award, Radiological Society of North America

• 【受賞】2015　Certificate of Futured abstract, International Japanese Society of Interventional Radiology

• 【受賞】2015　The best paper, Japanese Society of Implantable Port

• 【受賞】2017　JVIR Editor’s Award: Top of the Outstanding Laboratory Investigation Award

• 【受賞】2018　The best paper, Japanese Society for Palliative Medicine

SNS・ブログ等

• その他メディア
  • 奈良県立医科大学 放射線・核医学科
  • 【動画】血管治療編
  • 【動画】救急治療編
  • 【動画】がん治療編
  • 本医師との医学的知識共同研究をご希望の企業は、こちらからお問い合わせください。